Disposition of 46000 shares by Robertson Sanford of Cassava Sciences at 33.0 subject to Rule 16b-3
| SAVA Stock | USD 2.44 0.15 6.55% |
About 55% of Cassava Sciences' investors are presently thinking to get in. The analysis of overall sentiment of trading Cassava Sciences stock suggests that some investors are interested at this time. The current market sentiment, together with Cassava Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Cassava Sciences stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Cassava Sciences Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cassava Sciences Fundamental Analysis
We analyze Cassava Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cassava Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cassava Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Cassava Sciences is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Cassava Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cassava Sciences stock to make a market-neutral strategy. Peer analysis of Cassava Sciences could also be used in its relative valuation, which is a method of valuing Cassava Sciences by comparing valuation metrics with similar companies.
Peers
Cassava Sciences Related Equities
| ANVS | Annovis Bio | 6.77 | ||||
| BNGO | Bionano Genomics | 0.99 | ||||
| AVXL | Anavex Life | 0.65 | ||||
| NVAX | Novavax | 0.30 | ||||
| AXSM | Axsome Therapeutics | 2.77 | ||||
| IOVA | Iovance Biotherapeutics | 2.83 | ||||
| OCGN | Ocugen | 4.00 |
Complementary Tools for Cassava Stock analysis
When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |